Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci
Tomasz Jarzembowski
Department of Medical Microbiology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Profil OrcidWyszukaj tego autora
, Agnieszka Daca
Department of Pathology and Experimental Rheumatology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Profil OrcidWyszukaj tego autora
, Wiesław J. Cubała
Department of Psychiatry, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Profil OrcidWyszukaj tego autora
, oraz 09 sie 2022
O artykule